News

Inves Biofarm is pleased to announce the publication of the study that successfully supports the successful performance of an innovative cream using raw materials derived from up-cycling. The study used a polyphenolic extract from olive pomace – a by-product of olive oil production – encapsulated with sh-oligopeptide-1 using spray-drying technology. Clinical trials showed significant improvements in skin hydration, elasticity and barrier function after just one week of application.

We would like to thank our research team and the study participants, AINIA, UGR and the Dermatology Department of the Hospital Virgen de las Nieves in Granada for their dedication and commitment. At Inves Biofarm, we remain committed to providing scientifically backed, high quality skin care solutions.

View publication

We would like to announce that Inves Biofarm was present at the 27th edition of Cosmoprof Asia 2024, held in Hong Kong from 13th to 15th November. This event, which gathered more than 60,000 visitors, 2,400 exhibitors and representatives from 17 different countries, consolidated its position as the leading international B2B beauty trade fair in Asia. 

During these three days, Inves Biofarm took the opportunity to network with industry experts and distributors, raise product awareness and explore new business opportunities. 

We are grateful for this enriching experience, as our time at Cosmoprof Asia 2024 not only reflects the vitality of the industry, but also demonstrates Inves Biofarm’s commitment to excellence and innovation.

We are proud to announce that Inves Biofarm was present at Beautyworld Middle East, the largest and most visited beauty exhibition in the Middle East. From 28-30 October, the Dubai World Center was the epicentre of the beauty world, bringing together 70,000 visitors from over 150 countries and more than 2,000 exhibitors in 16 pavilions. 

This year, we went to great lengths to deliver an exceptional edition. We had the opportunity to showcase our Inveskin brand and our new products, including DermControl, our atopic dermatitis cream. At Inves Biofarm we are committed to offering the best in skin care, highlighting:

Clean room facilities for mesotherapy and products for the CE market.

Production of high quality vials and ampoules.

Sterilisation technology that ensures the outstanding quality of our products.

We are proud of our GMP, ISO 9001, ISO 22716 and ISO 13485 certifications, which support our commitment to quality and safety.

We would like to thank everyone who visited our stand and shared this experience with us. We look forward to continuing to innovate in the beauty and skin care industry.

Inves Biofarm has been collaborating with Zhejiang University on innovation and research projects for three years and we are proud to partner with such a prestigious international university. We will continue to expand our research networks to promote the innovations resulting from such scientifically high level collaborations at home and abroad.

We are proud to announce that on October 26th we participated in the symposium “Global perspectives for atopic dermatitis, united for better care” organized by ISAD (the International Society for Atopic Dermatitis).

On this occasion, during our presentation, we were able to present the results of the clinical study supporting the good compliance of a topical emulsion developed by Inves Biofarm for the treatment of atopic dermatitis (AD).

We will continue to provide innovative and high quality solutions for the research and development of dermatological diseases through topical formulations based on our patented biotechnological solution.

On 11 July, we participated as a speaker in the second meeting of INNOCOSMÉTICA. 

In her presentation entitled “Natural silk proteins and their use in cosmetics”, Ana Leticia, Research and Development Manager, highlighted Inves Biofarm’s commitment to the green economy through the rearing of the silkworm and the use of its waste, specifically the boiling of silk cocoons. This process yields two key proteins: fibroin and sericin, which have multiple applications in cosmetics, food and medicine due to their biocompatibility, minimal immunogenicity and biodegradability. 

He also presented our international patent on protein stabilisation, which ensures efficacy and safety in cosmetics, pharmaceuticals and topical medical devices. This innovative process uses neither heat nor water, ensuring complete biocompatibility. 

At Inves Biofarm, we’re not just innovating in biotechnology, we’re cultivating a future where science and nature come together to deliver sustainable solutions that improve people’s lives and protect our planet. 

Inves Biofarm has been recognised as an international success story by Andalucía TRADE, the Business Agency for Economic Change and Development of the Autonomous Community of Andalusia.

A few days ago, the Andalusia TRADE team visited our facilities to learn first-hand about our history, commitment and passion for research, development and innovation. It was an honour to show them how we work and our commitment to internationalisation so that the world knows what we do.

Andalucía TRADE published an interview with us. We invite you to read the full interview and get to know us better, link to the full article or you can see the publication in the IDEAL newspaper.

You can also find us on their communication platforms: Youtube, Facebook, Twitter (X), Instagram and LinkedIn.

We would like to thank Andalucía TRADE for this recognition. We are proud to show that we are an innovative and growing company.

Let’s keep moving forward together!

#InvesBiofarm #AndalucíaTrade #Innovation #Internationalisation #Growth #Recognition

Inves Biofarm participates in the 1st Ibero-American Congress of Diamagnetic Therapy and Regenerative Medicine

Inves Biofarm is proud to have participated in the 1st Iberoamerican Congress of Diamagnetic Therapy and Regenerative Medicine, held on 21 and 22 June at the University of Rosario in Bogota, Colombia.

The event, themed “Discover the Future of Medicine in the Heart of Ibero-America: Innovation, Connection, Inspiration”, brought together leaders and experts in biotechnology and advanced medical science. Attendees enjoyed lectures and interactive workshops on the latest advances in biotechnology and regenerative medicine, as well as making valuable professional connections.

Inves Biofarm, always at the forefront of biotechnology, presented our latest research. Our participation also reaffirms our commitment to developing innovative solutions. We are continuing with our mission to differentiate ourselves in the market and demonstrate that we are a leading and innovative company in our sector.

Inves Biofarm at the #BIO2024 in San Diego

From 2 to 6 June, Inves Biofarm attended the Bio International Convention in San Diego, California, one of the most important events in the biotech sector, which brought together more than 18,500 industry leaders from around the world. 

During these days, we had the opportunity to showcase our latest innovative projects. Our stand reflected the commitment and passion we have at Inves Biofarm to develop solutions that make a difference. 

It was very enriching to be able to collaborate and exchange ideas, which is essential to continue the commitment to excellence and innovation that we bring to Inves Biofarm.

Inves Biofarm is pleased to announce the publication of the clinical study that has successfully demonstrated the high level of compliance with the treatment.

This breakthrough underlines our commitment to excellence in quality and scientific content.

We thank our research team and study participants for their dedication and commitment. 

At Inves Biofarm we remain committed to providing scientifically backed, high quality skin care solutions.

Click on the following link for more information: https://www.mdpi.com/2310-2861/10/6/370